TECHNOLOGY — TIPS™ platform

TIPS™ (Tolerance - Induing Phosphatidylserine) is Immunotolerx’s proprietary liposome-based platform engineered to deliver disease-specific antigens in a phosphatidylserine (PS)-enriched nanoparticle that mimics apoptotic cells to achieve targeted immunotolerance.

Mitigation of Immunogenicity

Leverage the body’s preferred tolerance pathway, apoptosis, to mitigate immunogenicity.

Immunology diagram explaining how phosphatidylserine exposure during apoptosis triggers macrophage signaling pathways that lead to immune tolerance through IL-10 and TGF-beta.

TIPS™ Platform is Modular and Versatile

Competitive Advantages of the TIPS™ Platform

Infographic highlighting the competitive advantages of the Immunotolerx TIPS lipid nanoparticle platform for antigen-specific immune tolerance therapy and immunogenicity mitigation.